Opgen Inc (OPGN) |
|
2.4 0.08 (3.45%)
|
06-18 07:31 |
|
Open: |
2.28 |
Pre. Close: |
2.32 |
|
High:
|
2.48 |
Low:
|
2.28 |
|
Volume:
|
1,269,343 |
Market Cap:
|
92M |
|
|
|
|
OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. The company is headquartered in Gaithersburg, Maryland and currently employs 50 full-time employees. The firm is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. The company is working to deliver its molecular information solution to a global network of customers and partners. The company is also working to provide precise diagnostic information powered by pathogen surveillance data. The firm's high-resolution DNA tests are marketed under the Acuitas trade name. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.482 - 2.5 |
2.5 - 2.513 |
|
Low:
|
2.249 - 2.267 |
2.267 - 2.28 |
|
Close:
|
2.376 - 2.404 |
2.404 - 2.426 |
|
Technical analysis |
as of: 2021-06-17 4:45:46 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 2.90  One year: 3.38 |
| Support: |
Support1: 2.13 Support2: 1.92 |
| Resistance: |
Resistance1: 2.48 Resistance2: 2.90 |
| Pivot: |
2.20 |
| Moving Average: |
MA(5): 2.28 MA(20): 2.17
MA(100): 2.45 MA(250): 2.27 |
| MACD: |
MACD(12,26): 0.02 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 75.56 %D(3): 64.38 |
| RSI: |
RSI(14): 59.94 |
| 52-week: |
High: 4.44 Low: 1.63 Change(%): 16.5 |
| Average Vol(K): |
3-Month: 123121 10-Days: 176256 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.OPGN has closed below upper band by 1.4%. Bollinger Bands are 52.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPGN's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 16 Jun 2021
Should You Accumulate OpGen Inc (OPGN) Stock Wednesday Morning? - InvestorsObserver
Tue, 15 Jun 2021
Is OpGen, Inc. (OPGN) A Good Stock To Buy Now? - Yahoo Finance
Thu, 10 Jun 2021
Opgen Inc (OPGN) falls -4.3670% for June 10 - Equities.com
Thu, 10 Jun 2021
Buy It or Sell It? OpGen Inc (NASDAQ:OPGN) - DRP Gazette
Wed, 09 Jun 2021
OpGen Announces Partial Adjournment of Annual Meeting for - GlobeNewswire
Wed, 09 Jun 2021
OpGen Group Company Ares Genetics Presents at AWS and Twist - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
38 |
| Shares Float (M) |
36 |
|
% Held by Insiders
|
0.05 |
|
% Held by Institutions
|
2.69 |
|
Shares Short (K)
|
864 |
|
Shares Short P. Month (K)
|
873 |
Stock Financials |
|
EPS
|
-1.659 |
|
EPS Est This Year
|
-0.420 |
|
EPS Est Next Year
|
-0.160 |
|
Book Value (p.s.)
|
0.850 |
|
Profit Margin
|
|
|
Operating Margin
|
-510.02 |
|
Return on Assets (ttm)
|
-44.7 |
|
Return on Equity (ttm)
|
-205.7 |
|
Qtrly Rev. Growth
|
64.8 |
|
Gross Profit (p.s.)
|
-0.251 |
|
Sales Per Share
|
0.110 |
|
EBITDA (p.s.)
|
-0.501 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-23 |
|
Levered Free Cash Flow (M)
|
-10 |
Stock Valuations |
|
PE Ratio
|
-1.45 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.82 |
|
Price to Sales
|
21.82 |
|
Price to Cash Flow
|
-3.93 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2019-08-28 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
